1-12 of 12
Armando Santoro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis

Clinical Trials & Observations
Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. LaCasce, Peter D. Cole, Craig H. Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2740–2752.
https://doi.org/10.1182/bloodadvances.2023012145
Published: 2024
Includes: Supplemental data
Journal Articles

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Clinical Trials & Observations
Pier Luigi Zinzani, Gilles Salles, Alison J. Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M. Barr, Neha Mehta-Shah, Graham P. Collins, Stephen M. Ansell, Joshua D. Brody, Eva Domingo-Domenech, Nathalie A. Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry J. Savage
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2400–2404.
https://doi.org/10.1182/bloodadvances.2023011030
Published: 2024
Includes: Supplemental data
Journal Articles

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study

Clinical Trials & Observations
Stephen M. Ansell, Paul J. Bröckelmann, Gottfried von Keudell, Hun Ju Lee, Armando Santoro, Pier Luigi Zinzani, Graham P. Collins, Jonathon B. Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J. Savage, Marek Trněný, Mariano Provencio, Ulrich Jäger, Wolfgang Willenbacher, Rachael Wen, Alev Akyol, Joanna Mikita-Geoffroy, Margaret A. Shipp, Andreas Engert, Philippe Armand
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6266–6274.
https://doi.org/10.1182/bloodadvances.2023010334
Published: 2023
Includes: Supplemental data
Journal Articles

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

Clinical Trials & Observations
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta-Shah, Julie Lisano, Rachael Wen, Alev Akyol, Alison J. Moskowitz
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5272–5280.
https://doi.org/10.1182/bloodadvances.2023010254
Published: 2023
Includes: Supplemental data
Journal Articles

Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand

Jasper J. P. van Beek, Simone Puccio, Clara Di Vito, Federica De Paoli, Elisa Zaghi, Michela Calvi, Alice Scarpa, Clelia Peano, Gianluca Basso, Javier Cibella, Chiara De Philippis, Barbara Sarina, Inna Timofeeva, Rossana Capizzuto, Daniele Mannina, Rossana Mineri, Jacopo Mariotti, Roberto Crocchiolo, Armando Santoro, Luca Castagna, Stefania Bramanti, Domenico Mavilio, Enrico Lugli
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3458–3468.
https://doi.org/10.1182/bloodadvances.2022007735
Published: 2023
Includes: Supplemental data
Journal Articles

Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A. Johnson, Jose S. R. de Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael Dickinson, Andrew McDonald, Muhit Özcan, Naohiro Sekiguchi, Ying Zhu, Monika Raut, Todd L. Saretsky, Akash Nahar, John Kuruvilla
Journal: Blood Advances
Blood Adv (2022) 6 (2): 590–599.
https://doi.org/10.1182/bloodadvances.2021004970
Published: 2022
Includes: Supplemental data
Journal Articles

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial

Clinical Trials & Observations
Umberto Ricardi, Mario Levis, Andrea Evangelista, Daniela Maria Gioia, Gian Mauro Sacchetti, Manuel Gotti, Alessandro Re, Michela Buglione, Vincenzo Pavone, Antonio Nardella, Luca Nassi, Manuela Zanni, Paola Franzone, Giovanni Piero Frezza, Alessandro Pulsoni, Lavinia Grapulin, Armando Santoro, Luigi Rigacci, Gabriele Simontacchi, Monica Tani, Francesco Zaja, Elisabetta Abruzzese, Barbara Botto, Vittorio Ruggero Zilioli, Delia Rota-Scalabrini, Roberto Freilone, Giovannino Ciccone, Andrea Riccardo Filippi, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4504–4514.
https://doi.org/10.1182/bloodadvances.2021005150
Published: 2021
Includes: Supplemental data
Journal Articles

Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial

Clinical Trials & Observations
Alex F. Herrera, Catherine Burton, John Radford, Fiona Miall, William Townsend, Armando Santoro, Pier Luigi Zinzani, David Lewis, Camilla Fowst, Satjit Brar, Bo Huang, Aron Thall, Graham P. Collins
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3387–3396.
https://doi.org/10.1182/bloodadvances.2021004511
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma

Clinical Trials & Observations
Panayiotis Panayiotidis, George A. Follows, Luigina Mollica, Arnon Nagler, Muhit Özcan, Armando Santoro, Don Stevens, David Trevarthen, Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani, Martin Dreyling
Journal: Blood Advances
Blood Adv (2021) 5 (3): 823–828.
https://doi.org/10.1182/bloodadvances.2020002910
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy

Clinical Trials & Observations
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, Angelo Michele Carella, Massimo Martino, Francesca Patriarca, Antonio Risitano, Stefania Bramanti, Alessandro Busca, Luisa Giaccone, Lucia Brunello, Emanuela Merla, Lucia Savino, Barbara Loteta, Giuseppe Console, Renato Fanin, Alessandra Sperotto, Luana Marano, Serena Marotta, Camilla Frieri, Simona Sica, Patrizia Chiusolo, Samia Harbi, Sabine Furst, Armando Santoro, Andrea Bacigalupo, Didier Blaise, Emanuele Angelucci, Domenico Mavilio, Luca Castagna, Benedetto Bruno
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3900–3912.
https://doi.org/10.1182/bloodadvances.2020001620
Published: 2020
Includes: Supplemental data
Journal Articles

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma

Chiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, Laura Giordano, Catalina Montes de Oca, Rémy Duléry, Reda Bouabdallah, Angela Granata, Raynier Devillier, Jacopo Mariotti, Barbara Sarina, Samia Harbi, Valerio Maisano, Sabine Furst, Thomas Pagliardini, Pierre-Jean Weiller, Claude Lemarie, Boris Calmels, Christian Chabannon, Armando Santoro, Mohamad Mohty, Didier Blaise, Luca Castagna
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1242–1249.
https://doi.org/10.1182/bloodadvances.2019001336
Published: 2020
Journal Articles

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Manuela Zanni, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, Francesca Ricci, Carmelo Carlo-Stella
Journal: Blood Advances
Blood Adv (2020) 4 (1): 136–140.
https://doi.org/10.1182/bloodadvances.2019000984
Published: 2020
Includes: Supplemental data